The Effect of Alcohol Consumption on Risk for Sepsis and ARDS
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Alcohol Intoxication & Intervention Scale
Alcohol Intoxication & Intervention Scale Alcohol affects each individual differently. The effect of alcohol on a person will vary according to the person's mood, the time of day, Standard Drink amount of food in the stomach, the mixer used, how fast the person One standard drink of beer drinks, and what and why they are drinking. There are a variety of One 12 oz bottle of beer positive and negative consequences related to drinking. One 12 oz can of beer One 8 oz glass of malt liquor (i.e. Blood Alcohol Level Old English, Mickey's) Once you know the definition of one standard drink (see chart to the One standard drink of wine right), you can estimate your Blood Alcohol Level (BAL). BAL levels One 4 oz glass of wine (pictured) represent the percent of your blood that is concentrated with alcohol. A One 3 ‐ 3.5 oz of fortified wine (i.e. BAL of .10 means that .1% of your bloodstream is composed of alcohol. port, sherry) One bottle of table wine is about 5 Some key factors that affect BAL: standard drinks How many standard drinks you drink One standard drink of hard alcohol Remember different drinks have different strengths either One 1.25 oz shot of hard liquor because of differences in proofs of hard liquor or because some (pictured) drinks contain more than one shot One mixed drink containing one 1.25 oz shot of hard liquor Food eaten along with drinking alcohol will result in a lower, One 750ml bottle of hard liquor ("a delayed BAL because the alcohol enters the bloodstream at a fifth") is about 17 standard drinks lower rate Intoxication and Intervention Scale Know the visible signs of intoxication. -
Alcohol Intoxication Withdrawal Adult
Provincial Clinical Knowledge Topic Alcohol Intoxication Withdrawal, Adult Emergency Department V 1.5 © 2018, Alberta Health Services. This work is licensed under the Creative Commons Attribution-Non-Commercial-No Derivatives 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. Disclaimer: This material is intended for use by clinicians only and is provided on an "as is", "where is" basis. Although reasonable efforts were made to confirm the accuracy of the information, Alberta Health Services does not make any representation or warranty, express, implied or statutory, as to the accuracy, reliability, completeness, applicability or fitness for a particular purpose of such information. This material is not a substitute for the advice of a qualified health professional. Alberta Health Services expressly disclaims all liability for the use of these materials, and for any claims, actions, demands or suits arising from such use. Document History Version Date Description of Revision Completed By / Revised By 1.1 July 2015 Completed document (2013) reformatted into Dr. Bullard / Carla new topic template Milligan 1.2 January Minor edits in the Rationale section and form 1 Dr. Bullard / Sarah 2016 info in general care section as well as addition Searle of CIWA-Ar Scoring Reference tool to appendix 1.3 May 2016 Minor edits made to working group Sarah Searle membership list 1.4 June Removed link to Center for Addiction and Dr. Bullard / Sarah 2017 Mental Health assessment and documentation Searle form on pg. 35. Documentation requirements will continue as per local practice at this time. -
Mechanisms of Ethanol-Induced Cerebellar Ataxia: Underpinnings of Neuronal Death in the Cerebellum
International Journal of Environmental Research and Public Health Review Mechanisms of Ethanol-Induced Cerebellar Ataxia: Underpinnings of Neuronal Death in the Cerebellum Hiroshi Mitoma 1,* , Mario Manto 2,3 and Aasef G. Shaikh 4 1 Medical Education Promotion Center, Tokyo Medical University, Tokyo 160-0023, Japan 2 Unité des Ataxies Cérébelleuses, Service de Neurologie, CHU-Charleroi, 6000 Charleroi, Belgium; [email protected] 3 Service des Neurosciences, University of Mons, 7000 Mons, Belgium 4 Louis Stokes Cleveland VA Medical Center, University Hospitals Cleveland Medical Center, Cleveland, OH 44022, USA; [email protected] * Correspondence: [email protected] Abstract: Ethanol consumption remains a major concern at a world scale in terms of transient or irreversible neurological consequences, with motor, cognitive, or social consequences. Cerebellum is particularly vulnerable to ethanol, both during development and at the adult stage. In adults, chronic alcoholism elicits, in particular, cerebellar vermis atrophy, the anterior lobe of the cerebellum being highly vulnerable. Alcohol-dependent patients develop gait ataxia and lower limb postural tremor. Prenatal exposure to ethanol causes fetal alcohol spectrum disorder (FASD), characterized by permanent congenital disabilities in both motor and cognitive domains, including deficits in general intelligence, attention, executive function, language, memory, visual perception, and commu- nication/social skills. Children with FASD show volume deficits in the anterior lobules related to sensorimotor functions (Lobules I, II, IV, V, and VI), and lobules related to cognitive functions (Crus II and Lobule VIIB). Various mechanisms underlie ethanol-induced cell death, with oxidative stress and Citation: Mitoma, H.; Manto, M.; Shaikh, A.G. Mechanisms of endoplasmic reticulum (ER) stress being the main pro-apoptotic mechanisms in alcohol abuse and Ethanol-Induced Cerebellar Ataxia: FASD. -
AN OPEN RANDOMIZED STUDY COMPARING DISULFIRAM and ACAMPROSATE in the TREATMENT of ALCOHOL DEPENDENCE AVINASH DE SOUSA* and ALAN DE SOUSA
Alcohol & Alcoholism Vol. 40, No. 6, pp. 545–548, 2005 doi:10.1093/alcalc/agh187 Advance Access publication 25 July 2005 AN OPEN RANDOMIZED STUDY COMPARING DISULFIRAM AND ACAMPROSATE IN THE TREATMENT OF ALCOHOL DEPENDENCE AVINASH DE SOUSA* and ALAN DE SOUSA Get Well Clinic And Nursing Home, 33rd Road, Off Linking Road, Bandra, Mumbai 400050, Maharashtra State, India (Received 11 March 2005; first review notified 6 June 2005; in final revised form 21 June 2005; accepted 2 July 2005; advance access publication 25 July 2005) Abstract — Aims: To compare the efficacy of acamprosate (ACP) and disulfiram (DSF) for preventing alcoholic relapse in routine clinical practice. Methods: One hundred alcoholic men with family members who would encourage medication compliance and accom- pany them for follow-up were randomly allocated to 8 months of treatment with DSF or ACP. Weekly group psychotherapy was also available. The psychiatrist, patient, and family member were aware of the treatment prescribed. Alcohol consumption, craving, and adverse events were recorded weekly for 3 months and then fortnightly. Serum gamma glutamyl transferase was measured at the start Downloaded from https://academic.oup.com/alcalc/article/40/6/545/125907 by guest on 27 September 2021 and the end of the study. Results: At the end of the trial, 93 patients were still in contact. Relapse (the consumption of >5 drinks/40 g of alcohol) occurred at a mean of 123 days with DSF compared to 71 days with ACP (P = 0.0001). Eighty-eight per cent of patients on DSF remained abstinent compared to 46% with ACP (P = 0.0002). -
Prevention of Alcohol Abuse and Illicit Drug Use Annual Awareness and Prevention Program Notice to System Offices Employees
Prevention of Alcohol Abuse and Illicit Drug Use Annual Awareness and Prevention Program Notice to System Offices Employees Alcohol abuse and illicit drug use disrupt the work and learning environment and create an unsafe and unhealthy workplace. To protect its employees and students and fully serve the citizens of Texas, The Texas A&M University System prohibits alcohol abuse and illicit drug use. This brochure, which is distributed annually, serves as an awareness and prevention tool for System Offices employees by providing basic information about A&M System policy and regulations, legal sanctions and health risks related to alcohol abuse and illicit drug use. Information about counseling, treatment and rehabilitation programs is included. As an employee of The Texas A&M University System, motivation. Drug use by a pregnant woman may cause you must abide by state and federal laws on controlled additional health complications in her unborn child. substances, illicit drugs and use of alcohol. In addition, you must comply with A&M System policy, which states: A&M System Sanctions The Texas A&M University System (system) strictly The A&M System’s drug and alcohol abuse policy and prohibits the unlawful manufacture, distribution, regulation are included in the System Orientation course possession or use of illicit drugs or alcohol on reviewed by new employees as part of their orientation. system property, and/or while on official duty and/or The policy and regulation are posted online at as part of any system activities. http://policies.tamus.edu/34-02.pdf and http://policies.tamus.edu/34-02-01.pdf. -
Alcohol Dependence, Withdrawal, and Relapse
Alcohol Dependence, Withdrawal, and Relapse Howard C. Becker, Ph.D. Continued excessive alcohol consumption can lead to the development of dependence that is associated with a withdrawal syndrome when alcohol consumption is ceased or substantially reduced. This syndrome comprises physical signs as well as psychological symptoms that contribute to distress and psychological discomfort. For some people the fear of withdrawal symptoms may help perpetuate alcohol abuse; moreover, the presence of withdrawal symptoms may contribute to relapse after periods of abstinence. Withdrawal and relapse have been studied in both humans and animal models of alcoholism. Clinical studies demonstrated that alcoholdependent people are more sensitive to relapse provoking cues and stimuli than nondependent people, and similar observations have been made in animal models of alcohol dependence, withdrawal, and relapse. One factor contributing to relapse is withdrawalrelated anxiety, which likely reflects adaptive changes in the brain in response to continued alcohol exposure. These changes affect, for example, the body’s stress response system. The relationship between withdrawal, stress, and relapse also has implications for the treatment of alcoholic patients. Interestingly, animals with a history of alcohol dependence are more sensitive to certain medications that impact relapselike behavior than animals without such a history, suggesting that it may be possible to develop medications that specifically target excessive, uncontrollable alcohol consumption. KEY WORDS: Alcoholism; alcohol dependence; alcohol and other drug (AOD) effects and consequences; neuroadaptation; AOD withdrawal syndrome; AOD dependence relapse; pharmacotherapy; human studies; animal studies he development of alcohol expectations about the consequences of drinking (Koob and Le Moal 2008). dependence is a complex and alcohol use. -
Alcohol Abuse and Acute Lung Injury and Acute Respiratory Distress
Journal of Anesthesia & Critical Care: Open Access Review Article Open Access Alcohol abuse and acute lung injury and acute respiratory distress syndrome Introduction Volume 10 Issue 6 - 2018 Alcohol is one of the most commonly used and abused beverage Fadhil Kadhum Zwer Aliqa worldwide. Alcohol is known to have numerous systemic health Private clinic practice, Iraq effects, including on the liver and central nervous system. From a respiratory standpoint, alcohol abuse has long been associated with Correspondence: Fadhil Kadhum Zwer Aliqaby, Private clinic practice, Iraq, Email an increased risk of pneumonia. More recently, alcohol abuse has been strongly linked in epidemiologic studies to development of Received: December 11, 2017 | Published: November 28, ARDS in at-risk patients. The first demonstration of an association 2018 between chronic alcohol abuse and ARDS was made by Moss et al, who retrospectively examined 351 patients at risk for ARDS.1 In this subsequent decreased phagocytosis and bacterial killing. Chronic cohort, 43% of patients who chronically abused alcohol developed alcohol use is similarly associated with altered neutrophil function and ARDS compared to only 22% of those who did not abuse alcohol, decreased superoxide production. Interestingly, chronic alcohol use with the effect most pronounced in patients with sepsis. This study decreases levels of granulocyte/macrophage colony stimulating factor was limited by its retrospective design, particularly since this design (GM-CSF) receptor and signaling in lung epithelium, which has been required that alcohol use history be obtained by chart review and shown to result in defective alveolar macrophage maturation. The documented history; furthermore, this study did not adjust for net effect of these abnormalities is an increased pulmonary bacterial concomitant cigarette smoking. -
Karla Luciana Magnani
Karla Luciana Magnani ESTUDO MORFO-FUNCIONAL, BIOQUÍMICO E IMUNOHISTOQUÍMICO DO APARELHO RESPIRATÓRIO EM RATOS EXPOSTOS À FUMAÇA DO CIGARRO E AO ÁLCOOL Tese apresentada ao Programa de Pós-graduação em Bases Gerais da Cirurgia Faculdade de Medicina de Botucatu UNESP-SP para a obtenção de Título de Doutor Área de Concentração: Reparação, Regeneração e Transplante de Tecidos e Órgãos. Orientador: Dr Antônio José Maria Cataneo Co-orientadora: Dra Daniele Cristina Cataneo BOTUCATU 2009 FICHA CATALOGRÁFICA ELABORADA PELA SEÇÃO TÉCNICA DE AQUISIÇÃO E TRATAMENTO DA INFORMAÇÃO DIVISÃO TÉCNICA DE BIBLIOTECA E DOCUMENTAÇÃO - CAMPUS DE BOTUCATU - UNESP Bibliotecária responsável: Selma Maria de Jesus Magnani, Karla Luciana. Estudo morfo-funcional, bioquímico e imunohistoquímico do aparelho respiratório em ratos expostos à fumaça do cigarro e ao álcool / Karla Luciana Magnani. – Botucatu : [s.n.], 2009. Tese (doutorado) – Faculdade de Medicina de Botucatu, Universidade Estadual Paulista, 2009. Orientador: Antônio José Maria Cataneo Co-orientadora: Daniele Cristina Cataneo Assunto CAPES: 40101126 1. Alcoolismo 2. Tabagismo 3. Pulmões - Doenças - Estudos experimentais CDD 618.39 Palavras chave: Alcoolismo; Apoptose; Estresse oxidativo; Ratos wistars; Tabagismo >$`:RVMQ : V%5 ]Q` IV :%61C1:` J: `V:C1<:M>Q RV : ]V_%1:5 HQI :'RV5 ]V`V0V`:JM:5]V`1 YJH1:V:GVRQ`1:?8 VR1HQ V : ]V_%1: : QRQ IV% `:I1C1:`V5 VI V]VH1:C :Q IV% ]:1 "%`1RV V 1IV` V :Q IV% I:`1RQ5 CV:JR`Q #QR`1$Q $V@15 _%V I:1 RQ _%V _%:C_%V` Q% `: ]VQ:IV:%61C1Q%J:HQJHC%>QRV :V :]:8$V@1 V:$`:RVMQ]Q`V -
Pennsylvania Drug and Alcohol Abuse Control Act."
§ 1690.101. Short title This act shall be known and may be cited as the "Pennsylvania Drug and Alcohol Abuse Control Act." § 1690.102. Definitions (a) The definitions contained and used in the Controlled Substance, Drug, Device and Cosmetic Act shall also apply for the purposes of this act. (b) As used in this act: "CONTROLLED SUBSTANCE" means a drug, substance, or immediate precursor in Schedules I through V of the Controlled Substance, Drug, Device and Cosmetic Act. "COUNCIL" means the Pennsylvania Advisory Council on Drug and Alcohol Abuse established by this act. "COURT" means all courts of the Commonwealth of Pennsylvania, including magistrates and justices of the peace. "DEPARTMENT." The Department of Health. "DRUG" means (i) substances recognized in the official United States Pharmacopeia, or official National Formulary, or any supplement to either of them; and (ii) substances intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in man or other animals; and (iii) substances (other than food) intended to affect the structure or any function of the body of man or other animals; and (iv) substances intended for use as a component of any article specified in clause (i), (ii) or (iii), but not including devices or their components, parts or accessories. "DRUG ABUSER" means any person who uses any controlled substance under circumstances that constitute a violation of the law. "DRUG DEPENDENT PERSON" means a person who is using a drug, controlled substance or alcohol, and who is in a state of psychic or physical dependence, or both, arising from administration of that drug, controlled substance or alcohol on a continuing basis. -
6.14 Alcohol Use Disorders and Alcoholic Liver Disease
6. Priority diseases and reasons for inclusion 6.14 Alcohol use disorders and alcoholic liver disease See Background Paper 6.14 (BP6_14Alcohol.pdf) Background The WHO estimates that alcohol is now the third highest risk factor for premature mortality, disability and loss of health worldwide.1 Between 2004 to 2006, alcohol use accounted for about 3.8% of all deaths (2.5 million) and about 4.5% (69.4 million) of Disability Adjusted Life Years (DALYS).2 Europe is the largest consumer of alcohol in the world and alcohol consumption in this region emerges as the third leading risk factor for disease and mortality.3 In European countries in 2004, an estimated one in seven male deaths (95 000) and one in 13 female deaths (over 25 000) in the 15 to 64 age group were due to alcohol-related causes.3 Alcohol is a causal factor in 60 types of diseases and injuries and a contributing factor in 200 others, and accounts for 20% to 50% of the prevalence of cirrhosis of the liver. Alcohol Use Disorders (AUD) account for a major part of neuropsychiatric disorders and contribute substantially to the global burden of disease. Alcohol dependence accounts for 71% of all alcohol-related deaths and for about 60% of social costs attributable to alcohol.4 The acute effects of alcohol consumption on the risk of both unintentional and intentional injuries also have a sizeable impact on the global burden of disease.2 Alcoholic liver disease (ALD) is the commonest cause of cirrhosis in the western world, and is currently one of the ten most common causes of death.5 Liver fibrosis caused by alcohol abuse and its end stage, cirrhosis, present enormous problems for health care worldwide. -
Lung Morphology and Growth of Rats Exposed to Tobacco Smoke and Alcohol1 Estudo Morfológico Dos Pulmões E Crescimento De Ratos
4 – ORIGINAL ARTICLE MODELS, BIOLOGICAL Lung morphology and growth of rats exposed to tobacco smoke and alcohol1 Estudo morfológico dos pulmões e crescimento de ratos expostos à fumaça do cigarro e ao álcool Karla Luciana MagnaniI, Daniele Cristina CataneoII, Vera Luiza CapelozziIII, Julio DefaveriIV, Erica Nishida HasimotoI, Antônio José Maria CataneoV IFellow PhD degree, Postgraduate Program in General Basis of Surgery, Botucatu School of Medicine, UNESP, Sao Paulo-SP, Brazil. Acquisition and interpretation of data, manuscript writing. IIPhD, Assistant Professor, Division of Thoracic Surgery, UNESP, Sao Paulo-SP, Brazil. Conception and design of the study. IIIPhD, Associate Professor, Department of Pathology, University of Sao Paulo (USP), Brazil. Acquisition and interpretation of data. IVPhD, Associate Professor, Department of Pathology, UNESP, Sao Paulo-SP, Brazil. Acquisition and interpretation of data. VPhD, Chairman, Full Professor, Division of Thoracic Surgery, UNESP, Sao Paulo-SP, Brazil. Conception, design, intellectual and scientific content of the study. ABSTRACT PURPOSE: Investigate the morphological effects of chronic exposure to tobacco smoke inhalation and alcohol consumption on the lungs and on the growth of rats. METHODS: Sixty male Wistar rats were divided into four groups: control, tobacco, alcohol, tobacco + alcohol, for a period of study 260 days. Morphological analysis was conducted by optical and electron microscopy. Rat growth was investigated by measuring the snout-anus length, body mass index and body weight. RESULTS: The three groups exposed to the drugs presented lower growth and lower weight than the control group. The percentages of alveolitis, bronchiolitis and the mean alveolar diameter were greater, particularly in the groups exposed to tobacco smoke, but were not significantly different from the control group. -
Global Status Report on Alcohol and Health WHO Library Cataloguing-In-Publication Data
Global status report on alcohol and health WHO Library Cataloguing-in-Publication Data Global status report on alcohol and health. 1.Alcoholism - epidemiology. 2.Alcohol drinking - adverse effects. 3.Social control, Formal - methods. 4.Cost of illness. 5.Public policy. I.World Health Organization. ISBN 978 92 4 156415 1 (NLM classification: WM 274) © World Health Organization 2011 All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; e-mail: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication.